Syrma SGS Technology (SYRMA) Q4 23/24 earnings summary

Executive summary

• Achieved record consolidated revenue of ₹32,124 million in FY24, up 54% year-over-year, with strong growth across all business verticals and geographies.

• Net profit attributable to owners stood at ₹1,073 million, with total comprehensive income of ₹1,232 million for FY24.

• Completed the acquisition of a 51% stake in Johari Digital Healthcare Limited, expanding into the MedTech segment and strengthening the portfolio.

• Board recommended a final dividend of ₹1.5 per share (15% of face value), subject to shareholder approval.

Financial highlights

• Consolidated revenue grew 54% year-over-year to ₹32,124 million; EBITDA rose 11% to ₹2,571 million; EBITDA margin at 8.0%.

• PAT increased marginally to ₹1,243 million; EPS at ₹6.06 (basic).

• Export revenue reached $100 million, contributing 26% of total revenue.

• Highest-ever quarterly sales of ₹11,490 million in Q4 FY24.

• ROCE at 9.9%, net debt to equity ratio at 0.13.

Outlook and guidance

• Strong demand outlook for electronics manufacturing, with India’s EMS sector projected to reach ₹6 trillion by FY26.

• Focus on expanding manufacturing footprint, investing in R&D, and scaling up new verticals including MedTech and EV components.

• Guidance for continued revenue growth, margin improvement, and capitalizing on global supply chain shifts.